Moderna on Tuesday announced that its coronavirus vaccine was found to be safe and 100% effective at protecting against COVID-19 in a Phase 3 trial of more than 3,700 participants between the ages of 12 and 17.

Why it matters: Moderna CEO Stéphane Bancel said the company plans to submit its data to global regulators in early June, paving the way for an emergency use authorization for adolescents.

This story is breaking news. Please check back for updates.